These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12583351)

  • 1. [The safety and registration of pharmaceuticals from the point of view of the medical practitioner].
    Kaiser RH
    Anaesthesist; 2002 Dec; 51(12):1029-37; quiz 1037-8. PubMed ID: 12583351
    [No Abstract]   [Full Text] [Related]  

  • 2. [The safety and registration of pharmaceuticals from the point of view of the medical practitioner].
    Kaiser RH
    Radiologe; 2002 Dec; 42(12):1016-24; quiz 1024-5. PubMed ID: 12602329
    [No Abstract]   [Full Text] [Related]  

  • 3. [The Therapeutic Drug Committee of German Physicians. 50 years in the service of drug safety in Germany].
    Müller-Oerlinghausen B; Tiaden JD
    Internist (Berl); 2002 Apr; 43(4):482, 485-92. PubMed ID: 12053404
    [No Abstract]   [Full Text] [Related]  

  • 4. A regulatory view of the Medicines Act in the United Kingdom.
    Andrews PA; Thompson GM; Ward C
    J Clin Pharmacol; 1984 Jan; 24(1):6-18. PubMed ID: 6368615
    [No Abstract]   [Full Text] [Related]  

  • 5. New law in Germany compensates patients for drug side-effects.
    Orellana C
    Lancet; 2002 Aug; 360(9331):471. PubMed ID: 12241734
    [No Abstract]   [Full Text] [Related]  

  • 6. European view toward incorporating adverse events into package inserts.
    Gundert-Remy U
    Drug Inf J; 1987; 21(1):47-50. PubMed ID: 10301496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The community clinical trial system EudraCT at the EMEA for the monitoring of clinical trials in Europe].
    Krafft H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):453-8. PubMed ID: 15830257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulating the safety of pharmaceuticals: the FDA, preemption, and the public's health.
    Gostin LO
    JAMA; 2009 May; 301(19):2036-7. PubMed ID: 19454642
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug injuries: Their registration and documentation from the viewpoint of the "Bundesgesundheitsamt" (federal health office)].
    KAERBER G
    Methods Inf Med; 1964; 3(3-4):127-31. PubMed ID: 14256384
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trials for medicinal products. New European and national legal rules].
    Kreutz G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):524-9. PubMed ID: 15887061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing risks versus benefits in drug therapy decisions.
    Lasagna L
    Clin Ther; 1998; 20 Suppl C():C72-9. PubMed ID: 9915092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of SUSARs. Clinical evaluation of single cases in terms of regulatory requirements].
    Wroblewski H; Schmickler M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):459-63. PubMed ID: 15830258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who is responsible for what?
    Rouzioux JM
    Fundam Clin Pharmacol; 1990; 4 Suppl 2():183s-187s. PubMed ID: 2093630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Vernacular of Risk--Rethinking Direct-to-Consumer Advertising of Pharmaceuticals.
    Greene JA; Watkins ES
    N Engl J Med; 2015 Sep; 373(12):1087-9. PubMed ID: 26287749
    [No Abstract]   [Full Text] [Related]  

  • 15. [The 12th amendment to the German Drug Law. Chances and obstacles for investigator-initiated clinical trials].
    Dreier G; Marx C; Schmoor C; Maier-Lenz H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):445-52. PubMed ID: 15830256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ethical problems in planning therapy studies].
    Baltzer J
    Kinderkrankenschwester; 2013 Jun; 32(6):216-9. PubMed ID: 23822052
    [No Abstract]   [Full Text] [Related]  

  • 17. Commentary by a child psychiatrist in industry on the assessment of drug safety.
    Allen AJ
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):288-91. PubMed ID: 17630860
    [No Abstract]   [Full Text] [Related]  

  • 18. Crying wolf on drug safety.
    Br Med J (Clin Res Ed); 1982 Jan; 284(6311):219-20. PubMed ID: 6799107
    [No Abstract]   [Full Text] [Related]  

  • 19. Unlicensed pharmaceutical preparations for clinical patient care: Ensuring safety.
    de Wilde S; de Jong MGH; Le Brun PPH; Guchelaar HJ; Schimmel KJM
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):3-8. PubMed ID: 29047193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission.
    Joffe S; Lynch HF
    N Engl J Med; 2018 Feb; 378(8):695-697. PubMed ID: 29320302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.